Invention Grant
US09139577B2 Sulfoximine substituted quinazolines for pharmaceutical compositions
有权
用于药物组合物的磺酰亚胺取代喹唑啉
- Patent Title: Sulfoximine substituted quinazolines for pharmaceutical compositions
- Patent Title (中): 用于药物组合物的磺酰亚胺取代喹唑啉
-
Application No.: US14315399Application Date: 2014-06-26
-
Publication No.: US09139577B2Publication Date: 2015-09-22
- Inventor: Andreas Blum , Dirk Gottschling , Armin Heckel , Joerg P. Hehn , Bernhard Schmid , Dieter Wiedenmayer
- Applicant: Andreas Blum , Dirk Gottschling , Armin Heckel , Joerg P. Hehn , Bernhard Schmid , Dieter Wiedenmayer
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP13174337 20130628
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D239/94 ; A61K31/517 ; C07D409/12 ; C07D401/12 ; C07D413/12 ; C07D411/12 ; C07D409/14 ; C07D495/10 ; C07D403/12 ; A61K45/06 ; A61K31/541 ; C07D401/14 ; C07D405/12 ; C07D417/04 ; C07D417/14
Abstract:
This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
Public/Granted literature
- US20150005278A1 SULFOXIMINE SUBSTITUTED QUINAZOLINES FOR PHARMACEUTICAL COMPOSITIONS Public/Granted day:2015-01-01
Information query
